Biotech Values

[apljack]

Biotech walking dead

I suspect wallstarb is just running numbers on the co.'s but don't think that RGDX is anywhere near dead (although I don't know why he would have included it in his analysis as it is sooooo tiny.)

2008 revenues: $7 million
2009 revenues: $9 million
2010 revenues: $21 million

shares outstanding: 19.5 million

They may not have that much cash ($2.5 million) but also don't have much debt ($328,000) and they are not a co. that burns all that much cash, so they have plenty of room to generate some buy offering stock.

JM2C

aj